UCI MEDICAL AFFILIATES INC
SC 13G/A, 2000-02-10
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: TRAVELERS FUND UL FOR VARIABLE LIFE INSURANCE, S-6, 2000-02-10
Next: SGI INTERNATIONAL, 4, 2000-02-10












                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G



                    Under the Securities Exchange Act of 1934
                                (Amendment No. 3)



                         UCI MEDICAL AFFILIATES, INC.
                                (Name of Issuer)




                Common     Stock,     Par    Value    $0.05    Per Share
                         (Title of Class of Securities)




                              902633 10 6
                            (CUSIP Number)




This amendment to Schedule 13G is being filed pursuant to Rule  101(a)(2)(ii) of
Regulation S-T.





                      (Continued on following pages.)








<PAGE>



CUSIP No.:  902633 10 6             13G
          ---------------



1.       NAMES OF REPORTING PERSONS
         IRS IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

         Marion Fletcher McFarland, III

2.       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP   (a)  /   /  (b)

3.       SEC USE ONLY


4.       CITIZENSHIP OR PLACE OF ORGANIZATION
         United States of America

                                      5.   SOLE VOTING POWER            681,294
Number of Shares
                                      6.   SHARED VOTING POWER                0
Beneficially Owned By
                                      7.   SOLE DISPOSITIVE POWER       681,294
Each Reporting Person With:
                                      8.   SHARED DISPOSITIVE POWER           0



9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 681,294

10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW(9)EXCLUDES CERTAIN SHARES/  /


11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  6.95 %


12.      TYPE OF REPORTING PERSON
                  IN



<PAGE>



                  The  statement  on Schedule  13G ( the  "Statement")  filed on
                  February  14,  1986 by  Marion  Fletcher  McFarland,  III with
                  respect to the common  stock,  par value  $0.05 per share (the
                  "Common Stock"), of UCI Medical  Affiliates,  Inc. as amended,
                  is hereby further amended by amendments to Item 4, Ownership.

Item 4.           Ownership.

                  Items 4(a),  (b), and (c) of the Statement are hereby  amended
                  by deleting the language  contained under Items 4(a), (b), and
                  (c) of the  Statement  and  substituting  in their  place  the
                  following:

                  "(a)     Amount Beneficially Owned:

                  Marion F. McFarland, III, M.D. has direct beneficial ownership
                  of  681,294  shares  of Common  Stock.  This  amount  includes
                  159,450  shares of Common  Stock  that Dr.  McFarland  has the
                  right to acquire pursuant to currently exercisable options and
                  options  exercisable  within 60 days  following  December  31,
                  1999, granted by the Company to Dr. McFarland.

                  (b)      Percent of Class: 6.95 %

                  (c)      Number of shares of Common Stock as to which
                           Marion Fletcher McFarland has:

                           (i)sole power to vote or to direct the vote: 681,294

                           (ii)shared power to vote or to direct the vote:  -0-

                           (iii)sole power to dispose or to direct the
                                disposition of: 681,294

                           (iv) shared power to dispose or to direct the
                                disposition of:  -0-"



                                    SIGNATURE

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete,  and
correct.



                              /s/  Marion  Fletcher   McFarland,III, MD
                                   Marion Fletcher McFarland, III, M.D.

Date: February 10, 2000





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission